Dr Wang pioneers the conceptual design of functional nanomaterials for drug delivery, especially mRNA delivery. ​As an early career researcher (PhD awarded in Oct, 2020), Dr. Wang is dedicated to solving biological problems using state-of-art- nanobiotechnology, making an outstanding contribution to the field of functional nanomaterials enabled drug delivery particularly mRNA delivery. Her research has generated new understandings at the intersection of materials chemistry, biochemistry and molecular biology. Her research includes: (1) Nanotechnology enabled antibiotic-free antibacterial strategies to address the threat of ever-increasing antibiotic resistance. (2) signature research of nanochemistry upregulated mRNA translation in hard-to-transfect antigen-presenting cells with enhanced mRNA delivery performance. (3) Controllable synthesis of silica based materials.


Dr. Wang completed her MPhil study in the University of Queensland (UQ) in 2016 and PhD study in UQ in October 2020. As an early career researcher, Dr.Wang has demonstrated a high impact track record relative to opportunity with award of Dean's award for Excellence in Higher Degree Research (2016), the high proportion (41%) of first-authored publications, 28% of which in the top 10% most cited publications worldwide (Scopus 24/03/2021). She has been actively engaged in a number of professional activities in the research fields, including RHD student supervision, assessment for the master research projects (BIOX7021), talks at national and international conferences (The Australian Colloid and Interface Symposium Brisbane hub, 2021; The Australasian Society for Stem Cell Research ECR Symposium, 2021; BioNano Innovation, 2020) and conference organization (The Australian Colloid and Interface Symposium Brisbane hub, 2021).

Industry Engagement

Dr. Wang has been actively involved in industrial projects, including nanotechnology enabled natural antibacterial protein formulated animal feed for Ridley (Australia's leading animal nutrition provider), highlighted as one of UQ Research Impacts and the development of silica-tea tree oil composites (Anpario) to tackle antibiotic resistance.


​Dr. Wang has established collaborations with researchers in Australia (UQ ; University of Newcastle and Griffith University) and overseas (Tongji University, China). These collaborations resulted in 6 co-authored publications in the field of nanotechnology based drug delivery, including anticancer drug, protein and mRNA.

Top 5 Key Publications

Yue Wang, Yannan Yang, Yiru Shi, Hao Song* and Chengzhong Yu, Advanced Materials, 2020, 32, 1904106
Yue Wang, Jie Tang, Yannan Yang, Hao Song, Jianye Fu, Zhengying Gu and Chengzhong Yu, Angewandte Chemie, 2020, 59, 2695-2699

Yue Wang and Chengzhong Yu, Angewandte Chemie, 2020, 59, 23374-23385

Yue Wang, Hao Song, Chao Liu, Ye Zhang, Yueqi Kong, Jie Tang, Yannan Yang and Chengzhong Yu, National Science Review, 2020, DOI: 10.1093/nsr/nwaa268

Yue Wang, Hao Song, Yannan Yang, Yang Liu, Jie Tang and Chengzhong Yu, Chemistry of Materials, 2018, 30, 5770-5776